Has Brent Wood received payments from drug or device companies?

Yes. Drug and device makers reported $94,167 in general payments to Brent Wood across 38 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brent Wood did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brent Wood come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brent Wood

Clinical Pathology/Laboratory Medicine · Seattle, WANPI 1689764540

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $74,950 of the $94,167 with a category attached, or 79.6%. Amgen accounts for 64.0% of it on its own, with 8 other manufacturers making up the rest. Among clinical pathology/laboratory medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$94,167in general payments, 2019–2025

Across 38 payments — averaging $2478.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$60K
Sysmex America, Inc.$24K
Beckman Coulter, Inc.$5K
AbbVie$2K
Roche Diagnostics International Ltd$1K
Astellas Pharma US Inc$1K
plus $248 from 3 others

$583,981in research payments, 2019–2025

Across 7 payments — averaging $83,426 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Amgen$518K
Beckman Coulter, Inc.$66K

What the payments were for

Consulting fees$74,95080%
Speaking & faculty fees$5,6886%
Travel & lodging$12,85214%
Food & beverage$6771%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	15	$60,223
Sysmex America, Inc.	10	$23,619
Beckman Coulter, Inc.	6	$5,203
AbbVie	1	$2,100
Roche Diagnostics International Ltd	1	$1,400
Astellas Pharma US Inc	2	$1,375
Abbott	1	$205
Phadia US Inc.	1	$28
Adaptive Biotechnologies Corporation	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Blincyto$55,750
C-FCM$20,925
NAVIOS$5,172
XF-1600$2,500
Venclexta$2,100
RDI Research$1,400
XOSPATA$1,300
Alinity$205

How this compares

$94,167 in reported general payments places this provider in the 95th percentile of 23 clinical pathology/laboratory medicine providers in Washington.

See all clinical pathology/laboratory medicine providers in Washington →

Other clinical pathology/laboratory medicine in Seattle

Wayne ChandlerSeattle$20K
Donald GuineeSeattle$9K
Keith JeromeSeattle$8K
Alexander GreningerSeattle$3K
Michael AstionSeattle$2K
Runjun KumarSeattle$982
Maria TretiakovaSeattle$730
Sean MurphySeattle$450
James DetterSeattle$266
Maryam AsifSeattle$193

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →